Li, C., Wing, M. R., Reeser, J., Samorodnitsky, E., Pan, X. J., Risch, Z., Stein, L., Smith, A., Dao, T., Roychowdhury, S. (2025). A phase IIa clinical trial of first-line cyclical therapy alternating gemcitabine, cisplatin, and durvalumab with pemigatinib for advanced biliary tract cancers with FGFR2 -alterations.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps645